Beer, Tomasz M <br/><br/>
Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study.  [electronic resource] 

 -  Anti-cancer drugs  Oct 2006 
 - 1075-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/01.cad.0000231476.84782.55  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Luteinizing Hormone--blood<br/>Male<br/>Middle Aged<br/>Oligopeptides--administration & dosage<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Testosterone--blood